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Genetic Characterization and Emergence of the Metallo--Lactamase
GIM-1 in Pseudomonas spp. and Enterobacteriaceae during a Long-
Term Outbreak
Andreas F. Wendel,a Alexander H. B. Brodner,a* Stephan Wydra,a* Soﬁja Ressina,a Birgit Henrich,a Klaus Pfeffer,a Mark A. Toleman,b
Colin R. MacKenziea
Institute of Medical Microbiology and Hospital Hygiene, University Hospital, Heinrich-Heine-University, Düsseldorf, Germanya; Section of Medical Microbiology, Infection
and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdomb
Since the first isolation in 2002, the metallo--lactamase GIM-1 has not been detected outside Germany. The data presented
here, for 50 clinical blaGIM-1-positive isolates, including Pseudomonas spp. and Enterobacteriaceae (Enterobacter cloacae, Kleb-
siella oxytoca, Serratia marcescens, Escherichia coli, and Citrobacter freundii), collected between 2007 and 2012 at the original
site in an ongoing outbreak, demonstrate a diverse genetic background and dissemination of the gene conferring resistance to
enteric bacteria.
Metallo--lactamases (MBLs) hydrolyze all -lactams (exceptmonobactams), including the carbapenems, and thus are an
important emerging obstacle to the treatment of Gram-negative
bacterial nosocomial infections. To date, at least 11 subgroups
have been described, with IMP, VIM, and NDM-1 being the most
geographically widespread, while others, like GIM-1, have not be-
come globally established (1–3). The prevalence of MBLs in
Germany is low and mainly due to VIM types (4; http://ecdc
.europa.eu/en/activities/surveillance/EARS-net/database/Pages
/database.aspx). GIM-1 was initially discovered in a Pseudomonas
aeruginosa clone isolated from the surgical intensive care unit
(ICU) of the University Hospital of Düsseldorf (Germany) in
2002, in which the blaGIM-1 gene was located on a small 22-kb
nontransferable plasmid embedded in the class 1 integron In77
(5). Since then, GIM-1 has been described in only a few isolates of
Enterobacter cloacae, Serratia marcescens, Acinetobacter pittii, and
P. aeruginosa (6–9), nearly exclusively in the greater Düsseldorf
region and never outside Germany.
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TABLE 1 Carbapenemase multiplex primers and probes
Gene Primer/probe Sequence (5=¡3=)a Reference
Nucleotide
positions Size (bp)
blaGIM-1 GIM1-F CGACACACCTTGGTCTGAAGAA AJ620678 1232–1253 81
GIM1-R GATGCTAGCCATAACCTGGTATCC 1313–1290
GIM1-P HEX-ACACGAAGTTGTTATTATCCTGGGCGACTGAC-BHQ-1 1255–1286
blaVIM-1 VIM1-F TGCGCTTCGGTCCAGTAGA FJ172675 698–716 76
VIM1-R TGACGGGACGTATACAACCAGAT 774–752
VIM-P FAM-CTTCTATCCTGGTGCTGCGCATTCG-BHQ-1 720–744
blaVIM-2 VIM2-F GCGCTTCGGTCCAGTAGAAC AF191564 1810–1829 80
VIM2-R CTCGCAGACGGGACGTACA 1890–1872
VIM-P Same probe as for blaVIM-1 1831–1855
blaIMP-1 IMP1-F GGGCGGAATAGAGTGGCTTA AY168635 303–322 93
IMP1-R GGCTTGAACCTTACCGTCTTTTT 396–374
IMP1-P HEX-CGATCTATCCCCACGTATGCATCTGAATTAACA-BHQ-1 328–360
blaNDM-1 NDM1-F CGGCATCACCGAGATTGC FN396876 2547–2564 73
NDM1-R CACCGACATCGCTTTTGGT 2620–2602
NDM1-P FAM-GCGACTTGGCCTTGCTGTCCTTG-BHQ-1 2568–2590
a HEX, hexachlorofluorescein; BHQ-1, black hole quencher 1; FAM, 6-carboxyfluorescein.
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TABLE 2 Characteristics of blaGIM-1-positive strains ordered by species and isolation date
a
Species and strain M no.
Date
(yr or mo-yr) First sample type Ward
repPCR
type PFGE type Integron type Genetic location
Plasmid
size(s) (kb)
Pseudomonas aeruginosa
0 2002 Respiratory tract SICU PSA-1 PSA-A In77 C/P 22
19 Oct-07 Wound SW1 PSA-4 PSA-B In853 C
1 Dec-07 Respiratory tract MICU2 PSA-5 PSA-C In583* C
2 Jan-08 Stool MW3 PSA-6 PSA-D In851* C
4 Apr-08 Urine MW2 PSA-1 PSA-A In77* C
3 Apr-08 Respiratory tract SICU PSA-1 PSA-A In77 C
5 Jun-08 Respiratory tract SICU PSA-1 PSA-A In77 C
7 Sep-08 Respiratory tract MICU1 PSA-2 PSA-E In770 C
8 Sep-08 Respiratory tract MICU1 PSA-2 PSA-A In770* C
10 Oct-08 Stool MICU1 PSA-2 PSA-F In770 C
16 Feb-10 Respiratory tract SICU PSA-1 ND In77 C
25 Feb-10 Urine MW2 PSA-1 PSA-A In77 C
28 May-10 Urine MOP PSA-7 PSA-G In770 ND
29 May-10 Respiratory tract SICU PSA-8 PSA-H In851 C
45 Nov-10 Respiratory tract SICU PSA-1 PSA-A In77b C
46 Dec-10 Respiratory tract SICU PSA-1 PSA-A In77b C
47 Dec-10 Urine MW1 PSA-1 PSA-A In77b C
48 Mar-11 Wound SICU PSA-1 PSA-A In77b C
57 Apr-11 Respiratory tract SICU PSA-1 PSA-A In77b C
49 May-11 Respiratory tract SICU PSA-1 PSA-A In77b C
50 Jun-11 Urine SICU PSA-1 PSA-A In77b C
51 Jun-11 Respiratory tract SICU PSA-1 PSA-A In77b C
53 Jun-11 Respiratory tract SICU PSA-1 PSA-A In77b C
52 Jun-11 Respiratory tract SICU PSA-1 PSA-A In77b C
55 Jul-11 Respiratory tract SICU PSA-1 PSA-A In77b C
58 Sep-11 Wound SICU PSA-1 PSA-A In77b C and P 25
63 Dec-11 Respiratory tract SICU PSA-1 PSA-A In77b* C
64 Jan-12 Wound SICU PSA-1 PSA-A In77b C
67 Mar-12 Wound SICU PSA-1 PSA-A In77b C
68 Mar-12 Urine MW1 PSA-3 PSA-A In770 C
69 Apr-12 Wound SICU PSA-1 PSA-A In851 C
70 May-12 Respiratory tract SICU PSA-1 PSA-A In77b C
71 May-12 Respiratory tract MW4 PSA-3 PSA-D In851 C
Enterobacter cloacae
14 Jun-09 Urine MW4 ENT-1 ND In770 C and two P 25 and 220
15 Jan-10 Blood culture MICU1 ENT-1 ND In770* C and two P 25 and 220
21 Mar-10 Wound MW2 ENT-2 ND In770 C and two P 25 and 220
35 Jul-10 Urine MW3 ENT-2 ND In770 C and two P 25 and 220
44 Aug-10 Urine MW3 ENT-2 ND In770 C and two P 25 and 220
60 Dec-11 Wound MW3 ENT-1 ND In770 C and two P 25 and 220
65 Dec-11 Urine MW3 ENT-2 ND In770 C and two P 25 and 220
Pseudomonas putida
18 Sep-07 Urine MW3 PUT-3 ND In770* C
6 Sep-08 Stool MW3 PUT-1 ND In853* C
12 Dec-08 Urine MW3 PUT-1 ND In853 C
37 Aug-10 Urine MW3 PUT-2 ND In853 C
38 Aug-10 Urine MW3 PUT-2 ND In853 C
Serratia marcescens
9 Sep-08 Urine MICU2 ND SMA-A In770* P 140
11 Nov-08 Urine SW2 ND SMA-B In770 C
Escherichia coli 17 Mar-07 Blood culture MW5 ND ND In852* C and two P 50 and 130
Klebsiella oxytoca 43 Oct-10 Urine MW3 ND ND In770* C
Citrobacter freundii 56 Jul-11 Wound SICU ND ND In851* C
a MBL-positive isolates were given consecutive numbers with the prefix M. DiversiLab repPCR cluster and PFGE types were given numbers and letters, respectively, with an
acronym of the species. M0 (73-5671) was collected in 2002 and blaGIM-1 was described by Castanheira et al. (5) on a 22-kb plasmid, while we detected it chromosomally. *,
integron sequences were published in GenBank (JX566704 to JX566715) and given INTEGRALL numbers as shown (In77b being a variant of In77). SICU, surgical intensive care
unit; MICU, medical intensive care unit; SW, surgical ward; MW, medical ward (numbers indicate different wards); ND, not determined (M28 and M16 strains lost for further
analysis); C, chromosome; P, plasmid.
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A total of 230 clinical isolates collected between 2007 and 2012
in one hospital, fulfilling the criteria of nonsusceptibility to pip-
eracillin-tazobactam or ceftazidime and imipenem/meropenem,
were further screened for MBL by using MBL MIC test strips (Lio-
filchem, Roseto degli Abruzzi, Italy) and real-time in-house PCR
targeting the blaIMP-1, blaVIM-1-type, blaVIM-2-type, blaGIM-1, and
blaNDM-1 genes (Table 1). The blaGIM-1 gene was detected in 50
isolates (Pseudomonas aeruginosa [33], Enterobacter cloacae [7],
Pseudomonas putida [5], Serratia marcescens [2], Escherichia coli
[1], Klebsiella oxytoca [1], and Citrobacter freundii [1]). Other iso-
lates contained blaVIM-1 (2), blaVIM-2 (2), or blaNDM-1 (1). All
blaGIM-1-positive isolates except the single E. coli isolate (MIC, 8
mg/liter) were highly resistant to imipenem and meropenem
(MIC,32 mg/liter), and all blaGIM-1-positive isolates were addi-
tionally resistant to quinolones and aminoglycosides. The genetic
relatedness of the P. aeruginosa, P. putida, and E. cloacae isolates
was investigated using DiversiLab repetitive-sequence-based PCR
(repPCR) (bioMérieux, Nürtingen, Germany) according to the
manufacturer’s protocol. A similarity of 95% between isolates
was defined as representing a genetic cluster. Pulsed-field gel elec-
trophoresis (PFGE) was performed on all P. aeruginosa and Serra-
tia marcescens isolates by using SpeI (Fermentas, ThermoFisher,
Schwerte, Germany) as described previously (10) and interpreted
according to the criteria of Tenover et al. (11). One isolate of the
“original” P. aeruginosa clone, 73-5671 (5), was included. These
fingerprinting data (Table 2) revealed one main PFGE cluster of
24 P. aeruginosa isolates (PSA-A), including isolates from 2002 to
2012, nearly all of which (19 of 24) were isolated from the surgical
ICU, suggesting an ongoing clonal spread. The genetic relatedness
of all species is shown in Table 2.
We determined the genetic environment of the blaGIM-1 gene
by targeting conserved sequences of class 1 integrons by PCR and
using a walking sequencing strategy. In addition to detecting the
three integron types described before (5, 6, 8, 9), we detected four
new arrays (In77b, In851, In852, and In853) (Fig. 1). The blaGIM-1
gene cassette was fused to aacA4 in all isolates, except in P. aerugi-
nosaM1 (fused to aadB). Five integron arrays (In77, In77b, In770,
In851, and In853) were related to each other, sharing identical
elements (aacA4, aadA1, and blaOXA-2). The integron found in E.
coli M17 (In852) had a unique structure with different elements
(IS1600 and blaOXA-10) suggesting an enhanced degree of mobil-
ity of the blaGIM-1-aacA4 gene pair. All integron types (except
In852) were found in P. aeruginosa, and the appearance of the
same types, e.g., In851 and In770, in other Pseudomonas spp. and
Enterobacteriaceae (Table 2) clearly demonstrates horizontal gene
transfer of a large block of genetic information rather than an
individual gene.
S1 restriction and in-gel detection, performed as previously
described (10), using a 32P-radiolabeled blaGIM-1 probe (product
of primers 5.1.R2 [CCAAGCAGCAAGCGCGTTAC] and GIMR
[ACTCATGACTCCTCACGAGG] [5]), demonstrated the chro-
mosomal location of the gene in all isolates other than S.
marcescensM9, in which it was found only on a 140-kb plasmid. In
addition to being localized on the chromosome, the gene was
present on two plasmids in all E. cloacae isolates (approximately
25 kb and 220 kb) and inE. coliM17 (approximately 50 kb and 130
kb). Interestingly, we were able to detect blaGIM-1 on a plasmid (25
kb), similar in size to that originally described in 2004 (5), in only
one P. aeruginosa isolate (M58, belonging to PFGE type PSA-A).
S1 nuclease treatment, uncommon at the time of the first descrip-
tion of GIM-1, should detect plasmids of this small size, and thus
we suggest that the plasmid originally described is probably un-
stable and has been lost during cultivation or storage. As there is a
dominant chromosomal blaGIM-1-mediated resistance in our iso-
lates and as the blaGIM-1 gene cassette has moved into plasmids of
different sizes, transfer options besides plasmid-mediated trans-
fer, such as transfer of transposons or integrative and conjugative
elements (ICE) (12), must be considered. Horizontal gene transfer
was demonstrated by conjugation experiments using the recipient
E. coli rifampin-resistant C600 or sodium azide-resistant J53
strain on sheep blood agar at a recipient/donor ratio of 1:10 at
three temperatures (18°C, 30°C, and 37°C) as previously de-
scribed (13). Selective media contained 100 mg/liter ampicillin
and either 100 mg/liter rifampin or 100 mg/liter sodium azide.
Successful transfer was confirmed by real-time PCR targeting
blaGIM-1 and by use of random amplified polymorphic DNA
(RAPD) with four primers: Eric1-R, ERIC2 (14), 272 (15), and
1254 (16). We were able to prove only horizontal gene transfer in
vitro for the E. coli M17 isolate; the acquired resistance had no
impact on carbapenem susceptibility in the transconjugant.
The emergence of metallo--lactamase genes, first recovered
in nonfermenters and recently spread to Enterobacteriaceae, poses
a serious threat, since these bacteria are a common cause of severe
nosocomial infections. This is the first description of a large num-
ber of isolates expressing the blaGIM-1 gene, including a much
broader range of clinically relevant enteric bacteria than previ-
ously described. The originally described P. aeruginosa clone (5)
may have acted as a genetic pool in the hospital environment over
10 years for the bacterial community, since it was the first de-
scribed host of GIM-1. Although there is a considerable transfer of
patients between hospitals in the greater Düsseldorf area, there
does not seem to be an equivalent spread of our blaGIM-1-carrying
FIG 1 Class 1 integron arrays associated with blaGIM-1 found in this study.
Open reading frames are represented by open boxes with arrows indicating the
reading direction. IS1394 inserting into gene aadA1 is shown in gray.
Wendel et al.
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organisms, as there are only few isolates described elsewhere (6, 8,
9). Despite the data presented here, carbapenemase production in
Gram-negative bacteria remains relatively uncommon in Düssel-
dorf, but these data may herald a rise in GIM-1-mediated carbap-
enem resistance in this region, which is of great concern.
Nucleotide sequence accession numbers. Integron sequences
are published in GenBank under accession numbers JX566704 to
JX566715.
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